Pharmafile Logo

News and Press Releases

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital™ PCR technology 23 April 2025 -- Colorado,...

Category: BioManufacturing, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 23, 2025

Biodesix
919 W Dillon Rd, Louisville, CO 80027

Bio-Rad Extends Range of Anti-Biotherapeutic Antibodies to Accelerate Antibody Drug Development

Four New Anti-Idiotypic Antibodies and a New Anti-MMAE Antibody Range Support Bioanalytical Assay Development for Preclinical Research and Clinical Trials June 24 2024, California, US, -Bio-Rad Laboratories, Inc. (NYSE: BIO...

Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: June 24, 2024

Bio-Rad
UK_contact@bio-rad.com
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Bio-Rad Launches First Ultrasensitive Multiplexed Digital PCR Assay for Breast Cancer Mutation Detection in Clinical Research

Highly Sensitive and Multiplexed Assay for the Detection, Discrimination and Quantification of Key Mutations in ESR1 Gene for Breast Cancer, Developed for Bio-Rad’s QX600 Droplet Digital PCR System 2 April...

Category: Clinical Trials
Posted: April 2, 2024

Bio-Rad
UK_contact@bio-rad.com
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development

Range of Highly Selective Anti-Idiotypic Antibodies Now Includes Six Antibodies Specific to Dupilumab and its Biosimilars for Bioanalysis and Drug Monitoring 5 October 2023 -- California, US -- Bio-Rad Laboratories,...

Category: Drug Discovery
Posted: October 5, 2023

Bio-Rad
UK_contact@bio-rad.com
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET

Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers 

Superior thermal performance and enhanced usability for PCR applications, such as sequencing, cloning and genotyping.  28 September 2023 -- California, US -- Bio-Rad Laboratories, a global leader in life science...

Category: Drug Discovery
Posted: September 28, 2023

Bio-Rad
UK_contact@bio-rad.com
Bio-Rad Laboratories Ltd. The Junction Station Road Watford Hertfordshire WD17 1ET